Sessa Capital IM, L.P. - XERIS PHARMACEUTICALS INC ownership

XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 101 filers reported holding XERIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.

Quarter-by-quarter ownership
Sessa Capital IM, L.P. ownership history of XERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$8,970,000
-39.8%
3,661,2370.0%0.44%
-21.1%
Q2 2021$14,901,000
-3.3%
3,661,237
+7.1%
0.56%
-5.9%
Q1 2021$15,416,000
-24.9%
3,418,200
-18.1%
0.59%
-54.8%
Q4 2020$20,528,000
-17.0%
4,172,4590.0%1.31%
-35.0%
Q3 2020$24,743,000
+122.9%
4,172,4590.0%2.02%
+81.1%
Q2 2020$11,099,000
+76.1%
4,172,459
+29.1%
1.12%
+44.4%
Q1 2020$6,303,0003,232,4590.77%
Other shareholders
XERIS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Sessa Capital IM, L.P. 4,172,459$20,528,0001.31%
DELTEC ASSET MANAGEMENT LLC 693,870$3,414,0000.52%
Alpine Global Management, LLC 350,000$1,722,0000.35%
Redmile Group, LLC 2,397,441$11,795,0000.14%
Kamunting Street Capital Management, L.P. 43,833$216,0000.11%
IHT Wealth Management, LLC 250,798$1,234,0000.10%
SEARLE & CO. 34,000$167,0000.08%
GPS Wealth Strategies Group, LLC 46,025$226,0000.08%
ArrowMark Colorado Holdings LLC 1,981,909$9,751,0000.08%
Gladstone Institutional Advisory LLC 51,500$2530.05%
View complete list of XERIS PHARMACEUTICALS INC shareholders